A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an approximately $8 billion proposed settlement that would end tens of thousands of lawsuits alleging that the company’s baby powder and other talc products caused cancer.

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed attempts.

A Johnson & Johnson (NYSE:JNJ) subsidiary, Red River Talc, that has been formed to handle claims related to the healthcare giant's talc-based products, filed a voluntary prepackaged Chapter 11 bankruptcy case Friday to resolve current and future claims linked to ovarian cancer.

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an approximately $10 billion proposed settlement that would end tens of thousands of lawsuits alleging that the company's baby powder and other talc products caused cancer.

Beasley Allen opposed the Chapter 11 case, which includes up to $10 billion in nominal compensation to talc claimants. 'This proposed compensation is a gross undervaluation,' principal Andy Birchfield said in a statement to Law.

Johnson & Johnson revealed plans to pay an additional $1.1 billion to its talc settlement proposal to resolve thousands of suits, alleging that its baby and other talcum powder caused cancer.